Achala Vagal1, Bijoy K Menon2, Lydia D Foster2, Anthony Livorine2, Sharon D Yeatts2, Emmad Qazi2, Chris d'Esterre2, Junzi Shi2, Andrew M Demchuk2, Michael D Hill2, David S Liebeskind2, Thomas Tomsick2, Mayank Goyal2. 1. From the Department of Radiology (A.V, A.L, J.S, T.T), University of Cincinnati Medical Center, OH; Department of Public Health Sciences, Medical University of South Carolina, Charleston (L.F, S.Y); Department of Neurology, UCLA Medical Center (D.L); and Department of Clinical Neurosciences (A.D, M.H), Department of Radiology (B.M, E.Q, C.D, M.G, A.D., M.H.), Department of Community Health Sciences (M.H., B.M), and Department of Medicine (M.H.), University of Calgary, Calgary, Alberta, Canada. Achala.Vagal@uchealth.com. 2. From the Department of Radiology (A.V, A.L, J.S, T.T), University of Cincinnati Medical Center, OH; Department of Public Health Sciences, Medical University of South Carolina, Charleston (L.F, S.Y); Department of Neurology, UCLA Medical Center (D.L); and Department of Clinical Neurosciences (A.D, M.H), Department of Radiology (B.M, E.Q, C.D, M.G, A.D., M.H.), Department of Community Health Sciences (M.H., B.M), and Department of Medicine (M.H.), University of Calgary, Calgary, Alberta, Canada.
Abstract
BACKGROUND AND PURPOSE: Collateral flow can determine ischemic core and tissue at risk. Using the Interventional Management of Stroke (IMS) III trial data, we explored the relationship between computed tomography angiogram (CTA) collateral status and CT perfusion (CTP) parameters. METHODS: Baseline CTA collaterals were trichotomized as good, intermediate, and poor, and CTP studies were analyzed to quantify ischemic core, tissue at risk, and mismatch ratios. Kruskal-Wallis and Spearman tests were used to measure the strength of association and correlation between CTA collaterals and CTP parameters. RESULTS: A total of 95 patients had diagnostic CTP studies in the IMS III trial. Of these, 53 patients had M1/M2 middle cerebral artery±intracranial internal carotid artery occlusion, where baseline CTA collateral grading was performed. CTA collaterals were associated with smaller CTP measured ischemic core volume (P=0.0078) and higher mismatch (P=0.0004). There was moderate negative correlation between collaterals and core (rs=-0.45; 95% confidence interval, -0.64 to -0.20) and moderate positive correlation between collaterals and mismatch (rs=0.53; 95% confidence interval, 0.29-0.71). CONCLUSION: Better collaterals were associated with smaller ischemic core and higher mismatch in the IMS III trial. Collateral assessment and perfusion imaging identify the same biological construct about ischemic tissue sustenance.
BACKGROUND AND PURPOSE: Collateral flow can determine ischemic core and tissue at risk. Using the Interventional Management of Stroke (IMS) III trial data, we explored the relationship between computed tomography angiogram (CTA) collateral status and CT perfusion (CTP) parameters. METHODS: Baseline CTA collaterals were trichotomized as good, intermediate, and poor, and CTP studies were analyzed to quantify ischemic core, tissue at risk, and mismatch ratios. Kruskal-Wallis and Spearman tests were used to measure the strength of association and correlation between CTA collaterals and CTP parameters. RESULTS: A total of 95 patients had diagnostic CTP studies in the IMS III trial. Of these, 53 patients had M1/M2 middle cerebral artery±intracranial internal carotid artery occlusion, where baseline CTA collateral grading was performed. CTA collaterals were associated with smaller CTP measured ischemic core volume (P=0.0078) and higher mismatch (P=0.0004). There was moderate negative correlation between collaterals and core (rs=-0.45; 95% confidence interval, -0.64 to -0.20) and moderate positive correlation between collaterals and mismatch (rs=0.53; 95% confidence interval, 0.29-0.71). CONCLUSION: Better collaterals were associated with smaller ischemic core and higher mismatch in the IMS III trial. Collateral assessment and perfusion imaging identify the same biological construct about ischemic tissue sustenance.
Authors: Bruce C V Campbell; Søren Christensen; Brian M Tress; Leonid Churilov; Patricia M Desmond; Mark W Parsons; P Alan Barber; Christopher R Levi; Christopher Bladin; Geoffrey A Donnan; Stephen M Davis Journal: J Cereb Blood Flow Metab Date: 2013-05-08 Impact factor: 6.200
Authors: Michael P Marks; Maarten G Lansberg; Michael Mlynash; Jean-Marc Olivot; Matus Straka; Stephanie Kemp; Ryan McTaggart; Manabu Inoue; Greg Zaharchuk; Roland Bammer; Gregory W Albers Journal: Stroke Date: 2014-02-25 Impact factor: 7.914
Authors: L C S Souza; A J Yoo; Z A Chaudhry; S Payabvash; A Kemmling; P W Schaefer; J A Hirsch; K L Furie; R G González; R G Nogueira; M H Lev Journal: AJNR Am J Neuroradiol Date: 2012-03-01 Impact factor: 3.825
Authors: Bruce C V Campbell; Søren Christensen; Christopher R Levi; Patricia M Desmond; Geoffrey A Donnan; Stephen M Davis; Mark W Parsons Journal: Stroke Date: 2011-10-06 Impact factor: 7.914
Authors: Bijoy K Menon; Billy O'Brien; Andrew Bivard; Neil J Spratt; Andrew M Demchuk; Ferdinand Miteff; Xuewen Lu; Christopher Levi; Mark W Parsons Journal: J Cereb Blood Flow Metab Date: 2012-11-14 Impact factor: 6.200
Authors: Fabricio O Lima; Karen L Furie; Gisele S Silva; Michael H Lev; Erica C S Camargo; Aneesh B Singhal; Gordon J Harris; Elkan F Halpern; Walter J Koroshetz; Wade S Smith; Albert J Yoo; Raul G Nogueira Journal: Stroke Date: 2010-09-09 Impact factor: 7.914
Authors: Bruce C V Campbell; Peter J Mitchell; Timothy J Kleinig; Helen M Dewey; Leonid Churilov; Nawaf Yassi; Bernard Yan; Richard J Dowling; Mark W Parsons; Thomas J Oxley; Teddy Y Wu; Mark Brooks; Marion A Simpson; Ferdinand Miteff; Christopher R Levi; Martin Krause; Timothy J Harrington; Kenneth C Faulder; Brendan S Steinfort; Miriam Priglinger; Timothy Ang; Rebecca Scroop; P Alan Barber; Ben McGuinness; Tissa Wijeratne; Thanh G Phan; Winston Chong; Ronil V Chandra; Christopher F Bladin; Monica Badve; Henry Rice; Laetitia de Villiers; Henry Ma; Patricia M Desmond; Geoffrey A Donnan; Stephen M Davis Journal: N Engl J Med Date: 2015-02-11 Impact factor: 91.245
Authors: I Y L Tan; A M Demchuk; J Hopyan; L Zhang; D Gladstone; K Wong; M Martin; S P Symons; A J Fox; R I Aviv Journal: AJNR Am J Neuroradiol Date: 2009-01-15 Impact factor: 3.825
Authors: O Y Bang; J L Saver; B H Buck; J R Alger; S Starkman; B Ovbiagele; D Kim; R Jahan; G R Duckwiler; S R Yoon; F Viñuela; D S Liebeskind Journal: J Neurol Neurosurg Psychiatry Date: 2007-12-12 Impact factor: 10.154
Authors: Joseph P Broderick; Yuko Y Palesch; Andrew M Demchuk; Sharon D Yeatts; Pooja Khatri; Michael D Hill; Edward C Jauch; Tudor G Jovin; Bernard Yan; Frank L Silver; Rüdiger von Kummer; Carlos A Molina; Bart M Demaerschalk; Ronald Budzik; Wayne M Clark; Osama O Zaidat; Tim W Malisch; Mayank Goyal; Wouter J Schonewille; Mikael Mazighi; Stefan T Engelter; Craig Anderson; Judith Spilker; Janice Carrozzella; Karla J Ryckborst; L Scott Janis; Renée H Martin; Lydia D Foster; Thomas A Tomsick Journal: N Engl J Med Date: 2013-02-07 Impact factor: 91.245
Authors: K Nael; A Doshi; R De Leacy; J Puig; M Castellanos; J Bederson; T P Naidich; J Mocco; M Wintermark Journal: AJNR Am J Neuroradiol Date: 2017-12-07 Impact factor: 3.825
Authors: Ilko L Maier; Daniel Behme; Marlena Schnieder; Ioannis Tsogkas; Katharina Schregel; Mathias Bähr; Michael Knauth; Jan Liman; Marios-Nikos Psychogios Journal: PLoS One Date: 2017-03-10 Impact factor: 3.240